G.; Chung, M.; Trikalinos, T.; Mitrim, J; Brendel, M.; Patel, K.; Lichtenstein, A.H.; Lau, J.; Balk, E.M. Systematic evaluation: Vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 2010, 152, 307?14.Nutrients 2013,113. Esposti, M.D.; Ngo, A.; Ghelli, A.; Benelli, B.; Carelli, V.; McLennan, H.; Linnane, A.W. The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with all the respiratory complexes of heart mitochondria. Arch. Biochem. Biophys. 1996, 330, 395?00. 114. Ernster, L.; Dallner, G. Biochemical, physiological and medical elements of ubiquinone function. Biochim. Biophys. Acta 1995, 1271, 195?04. 115. McMurray, J.J.V.; Dunselman, P.; Wedel, H.; Cleland, J.G.F.; Lindberg, M.; Hjalmarson, A.; Kjekshus, J.; Waagstein, F.; Apetrei, E.; Barrios, V.; et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure. J. Am. Coll. Cardiol. 2010, 56, 1196?204. 116. Overvad, K.; Diamant, B.; Holm, L.; Holmer, G.; Mortensen, S.A.; Stender, S. Coenzyme Q10 in overall health and disease. Eur. J. Clin. Nutr. 1999, 53, 764?70. 117. Sander, S.; Coleman, C.I.; Patel, A.A.; Kluger, J.; White, C.M. The influence of coenzyme Q10 on systolic function in sufferers with chronic heart failure. J. Card. Fail. 2006, 12, 464?72. 118. Gao, L.; Mao, Q.; Cao, J.; Wang, Y.; Zhou, X.; Fan, L. Effects of coenzyme Q10 on vascular endothelial function in humans: A meta-analysis of randomized controlled trials. Atherosclerosis 2012, 221, 311?16. 119. Ho, M.J.; Bellusci, A.; Wright, J.M. Blood stress lowering efficacy of coenzyme Q10 for main hypertension.3-(Bromomethyl)-1,1-difluorocyclobutane Order Cochrane Database Syst. Rev. 2009, 4, CD007435. 120. Vandenberg, B.F.; Robinson, J. Management of your patient with statin intolerance. Curr. Atheroscler. Rep. 2010, 12, 48?7. 121. Bookstaver, D.A.; Burkhalter, N.A.; Hatzigeorgiou, C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am. J. Cardiol. 2012, 110, 526?29. 122. Supplements. National Institutes of Well being. Out there on the net: http://ods.od.nih.gov/factsheets/ magnesium.asp (accessed on 19 January 2010). 123. Seelig, M.S.; Rosanoff, A. The Magnesium Aspect; Avery: New York, NY, USA, 2003. 124. Liao, F.; Folsom, A.R.; Brancati, F.L. Is low magnesium concentration a risk factor for coronary heart illness? The Atherosclerosis Risk in Communities (ARIC) study. Am. Heart J. 1998, 136, 480?90. 125. Schulze, M.B.; Schulz, M.; Heidemann, C.; Schienkiewitz, A.; Hoffmann, K.; Boeing, H. Fiber and magnesium intake and incidence of kind two diabetes. A prospective study and meta-analysis. Arch. Intern. Med. 2007, 167, 956?65. 126. Shechter, M. Magnesium and cardiovascular technique. Magnes. Res. 2010, 23, 1?3. 127. He, K.; Liu, K.; Daviglus, M.tert-Butyl azetidin-3-ylcarbamate uses L.PMID:33493697 ; Loria, C.M.; Van Horn, L.; Jacobs, D.R., Jr.; Savage, P.J. Magnesium intake and incidence of metabolic syndrome amongst young adults. Circulation 2006, 113, 1675?682. 128. Shechter, M. Magnesium and cardiovascular method. Magnes. Res. 2010, 23, 60?2. 129. Stepura, O.B.; Martynow, A.I. Magnesium orotate in serious congestive heart failure (MACH). Int. J. Cardiol. 2009, 131, 293?95. 130. Shechter, M.; Sharir, M.; Labrador, M.; Forrester, J.; Silver, B.; Bairey Merz, C.N. Oral magnesium therapy improves endothelial function in patients with coronary artery illness. Circulation 2000, 102, 2353?358.Nutrients 2013,131. Shechter, M.; Bairey Merz, C.N.; Paul-Labrador, M.; Meisel, S.R.; Rude, R.K.; Molloy, M.D.; Dwyer, J.H.; Shah, P.K.; Kaul, S. Oral magnesium supplementation inhibits platelet-dependent.
